• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺素E增强人骨髓红系(BFU-E)祖细胞的增殖需要OKT8阳性T淋巴细胞的参与,并且与BFU-E上主要组织相容性复合体II类抗原的密度表达相关。

Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E.

作者信息

Lu L, Pelus L M, Broxmeyer H E, Moore M A, Wachter M, Walker D, Platzer E

出版信息

Blood. 1986 Jul;68(1):126-33.

PMID:3487351
Abstract

The relationship between major histocompatibility complex class II antigens (MHC class II, eg, HLA-DR, Ia), T lymphocytes, and the enhancement of erythroid colony formation from BFU-E by prostaglandin E was analyzed using normal bone marrow cells. In primary methylcellulose culture, the addition of prostaglandin E1 (PGE1) to unseparated buffy coat, low-density, or nonadherent low-density (NAL) marrow cells resulted in an enhancement of the total number of erythroid (BFU-E) colonies observed. Treatment of bone marrow cells with a monoclonal antihuman MHC class II antibody plus complement (C') resulted in a reduction of the total number of colonies by approximately 50% and abrogation of the enhancing effect of PGE1. Analysis of accessory cell requirements by depletion of both adherent cells and sheep erythrocyte rosetting lymphocytes (E+ cells) and reconstitution using C' or anti-MHC class II antibody plus C'-treated T cell-depleted NAL (NALT-) marrow cells and E+ cell populations treated with C' or anti-MHC class II antibody plus C' demonstrated a requirement for MHC class II antigen-T cells, but not adherent cells, and a requirement for MHC class II antigen + BFU-E in order to observe the enhancing effect of PGE1 on erythroid colony formation. Positive selection of BFU-E in NALT- bone marrow expressing differing density distributions of MHC class II antigens was accomplished with monoclonal anti-MHC class II antibodies and sorting with a fluorescence-activated cell sorter (FACS). Addition of E+ cells to the different populations of MHC class II antigen+ NALT- cells demonstrated that the PGE-enhancing effects on erythroid colony formation were directly related to increasing density distributions of MHC class II antigens on BFU-E. Colony formation by BFU-E expressing a low density distribution of MHC class II antigens or having no detectable MHC class II antigens, as determined by FACS analysis, was not enhanced by PGE1 in the presence of MHC class II antigen-positive or -negative T cells.

摘要

利用正常骨髓细胞分析了主要组织相容性复合体II类抗原(MHC II类,如HLA-DR、Ia)、T淋巴细胞以及前列腺素E对BFU-E红系集落形成的增强作用之间的关系。在原代甲基纤维素培养中,向未分离的血沉棕黄层、低密度或非贴壁低密度(NAL)骨髓细胞中添加前列腺素E1(PGE1),可使观察到的红系(BFU-E)集落总数增加。用单克隆抗人MHC II类抗体加补体(C')处理骨髓细胞,可使集落总数减少约50%,并消除PGE1的增强作用。通过去除贴壁细胞和绵羊红细胞花环形成淋巴细胞(E+细胞)并使用C'或抗MHC II类抗体加C'处理的T细胞耗尽的NAL(NALT-)骨髓细胞和用C'或抗MHC II类抗体加C'处理的E+细胞群体进行重建来分析辅助细胞需求,结果表明需要MHC II类抗原-T细胞,但不需要贴壁细胞,并且需要MHC II类抗原+BFU-E才能观察到PGE1对红系集落形成有增强作用。用单克隆抗MHC II类抗体并通过荧光激活细胞分选仪(FACS)分选,对表达不同密度分布MHC II类抗原的NALT-骨髓中的BFU-E进行阳性选择。将E+细胞添加到不同的MHC II类抗原+NALT-细胞群体中表明,PGE对红系集落形成的增强作用与BFU-E上MHC II类抗原密度分布增加直接相关。通过FACS分析确定,表达低密度分布MHC II类抗原或无可检测MHC II类抗原的BFU-E的集落形成,在存在MHC II类抗原阳性或阴性T细胞的情况下,PGE1不会增强其集落形成。

相似文献

1
Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E.前列腺素E增强人骨髓红系(BFU-E)祖细胞的增殖需要OKT8阳性T淋巴细胞的参与,并且与BFU-E上主要组织相容性复合体II类抗原的密度表达相关。
Blood. 1986 Jul;68(1):126-33.
2
Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.前列腺素E对人红细胞系(爆式红系集落形成单位)和多能(粒-红-巨核-巨噬细胞集落形成单位)祖细胞HLA-DR(Ia)抗原表达及增殖的调节作用
Exp Hematol. 1984 Oct;12(9):741-8.
3
Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.用My10和主要组织相容性复合体II类单克隆抗体通过双色细胞分选高度富集的成人人类骨髓造血祖细胞的特征分析
J Immunol. 1987 Sep 15;139(6):1823-9.
4
Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells.
Exp Hematol. 1987 Aug;15(7):765-71.
5
Target cell for prostaglandin E in the stimulation of in vitro human erythroid (BFU-E) progenitor cells: correlation of Ia antigen expression with the stimulatory effect.
Exp Hematol. 1986 Oct;14(9):873-7.
6
The comparative enhancing effects of prostaglandin E1 on colony formation by erythroid progenitor (BFU-E) cells from bone marrow of mice differing in the Fv-2 locus.
Leuk Res. 1987;11(6):501-7. doi: 10.1016/0145-2126(87)90084-1.
7
The role of marrow accessory cell populations in the augmentation of human erythroid progenitor cell (BFU-E) proliferation by prostaglandin E.
Leuk Res. 1989;13(7):527-34. doi: 10.1016/0145-2126(89)90119-7.
8
Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.Thy-1是一种分化抗原,可表征未成熟的小鼠红系和髓系造血祖细胞。
J Cell Physiol. 1985 Apr;123(1):25-32. doi: 10.1002/jcp.1041230105.
9
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.人类造血祖细胞亚群中II类主要组织相容性复合体抗原的差异表达。
Leukemia. 1988 Oct;2(10):677-86.
10
Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins.正常人多能(CFU - GEMM)和红系(BFU - E)祖细胞上Ia样抗原决定簇的细胞周期表达与酸性异铁蛋白体外调节的相关性。
Blood. 1983 Feb;61(2):250-6.

引用本文的文献

1
Recent advances in targeting COX-2 for cancer therapy: a review.靶向COX-2用于癌症治疗的最新进展:综述
RSC Med Chem. 2025 Apr 21. doi: 10.1039/d5md00196j.
2
Brief Story on Prostaglandins, Inhibitors of their Synthesis, Hematopoiesis, and Acute Radiation Syndrome.前列腺素简述、其合成抑制剂、造血作用和急性辐射综合征。
Molecules. 2019 Nov 6;24(22):4019. doi: 10.3390/molecules24224019.
3
Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy.环氧化酶-2:在癌症干细胞存活及治疗期间癌细胞再增殖中的作用
Stem Cells Int. 2016;2016:2048731. doi: 10.1155/2016/2048731. Epub 2016 Nov 1.
4
Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2.从你的骨髓中获取更多:用前列腺素E2提高造血干细胞数量。
Exp Cell Res. 2014 Dec 10;329(2):220-6. doi: 10.1016/j.yexcr.2014.07.030. Epub 2014 Aug 2.
5
Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.前列腺素 E2 在造血中的多效作用;前列腺素 E2 和其他类二十烷酸调节造血干细胞和祖细胞功能。
Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):3-9. doi: 10.1016/j.prostaglandins.2011.06.004. Epub 2011 Jun 21.
6
Erythropoiesis, anemia and the bone marrow microenvironment.红细胞生成、贫血与骨髓微环境。
Int J Hematol. 2011 Jan;93(1):10-3. doi: 10.1007/s12185-010-0759-6. Epub 2011 Jan 12.
7
Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking.二十烷酸类物质对造血作用和造血干细胞及祖细胞归巢的调控。
Leukemia. 2010 Dec;24(12):1993-2002. doi: 10.1038/leu.2010.216. Epub 2010 Sep 30.
8
Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow.B19细小病毒在来自正常人骨髓的高度富集造血祖细胞中的复制。
J Virol. 1988 Aug;62(8):3059-63. doi: 10.1128/JVI.62.8.3059-3063.1988.
9
Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.一种能够在体外形成含原始细胞集落的人造血祖细胞的特性分析。
J Clin Invest. 1988 Sep;82(3):1017-27. doi: 10.1172/JCI113658.